6Kang Y,Kang WK,Shin DB,et al.Randomized phase Ⅲ trial of capecitabine/cisplatin (XP) vs.continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC):efficacy and safety results[J].Proc Am Soc Clin Oncol,2006,24:a LBA4018.
7Lee SS,Lee JL,Ryu MH,et al.Combination chemotherapy with capecitabine (x) and cisplatin (p) as first line treatment in advanced gastric cancer:experience of 223 patients with prognostic factor analysis[J].Jpn J Clin Oncol,2007,37(1):30-37.
8Petrovic Z,Tarabar D,Doder R,et al.Oxaliplatin (L-OHP) and capecitabine (X) as second line chemotherapy in patients with advanced gastric cancer[J].Proc Am Soc Clin Oncol,2003,22:a1199.
9Park Y,Kim B,Ryoo B,et al.A phase Ⅱ study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer[J].Br J Cancer,2006,94(7):959-963.
10Park Y,Lee J,Ryoo B,et al.A phase Ⅱ study of capecitabine plus oxaliplatin (XELOX) as first-line therapy for patients with advanced gastric cancer[J].J Clin Oncol,2006,24(18S):4079.
